Related Experiment Videos

Empiric antibiotic therapy in a child with cancer and suspected septicemia

Desiree Caselli1, Olivia Paolicchi

  • 1Department Pediatric Hematology Oncology, Azienda Ospedaliera Universitaria Meyer Children Hospital, Firenze, Italy.

Pediatric Reports
|June 13, 2012
PubMed

Insights

Prompt antibiotic intervention is crucial for reducing mortality in children with cancer experiencing neutropenic fever. Empiric beta-lactam monotherapy is recommended for stable patients, while broader coverage is needed for those with systemic compromise.

Area of Science:

  • Pediatric Oncology
  • Infectious Diseases
  • Pharmacology

Background:

  • Childhood cancer treatment outcomes are improved by advanced cancer-directed therapies and supportive care.
  • Life-threatening infections are a major concern in pediatric cancer patients, necessitating prompt management.
  • Empiric antibiotic therapy has significantly reduced mortality rates in this vulnerable population.

Purpose of the Study:

  • To outline optimal empiric antibiotic strategies for febrile neutropenia in pediatric cancer patients.
  • To differentiate treatment approaches based on patient stability and risk factors.
  • To emphasize the importance of timely intervention in managing infectious complications.

Main Methods:

  • Review of current clinical guidelines and evidence for managing febrile neutropenia in pediatric oncology.
  • Analysis of recommended empiric antibiotic regimens based on patient presentation (stable vs. systemically compromised).
  • Consideration of specific antibiotic agents like piperacillin-tazobactam, cefepime, and gentamicin.

Main Results:

  • Prompt initiation of physical examination, blood tests, and blood cultures is essential.
  • Beta-lactam monotherapy (e.g., piperacillin-tazobactam, cefepime) is suitable for clinically stable patients with neutropenic fever.
  • An anti-pseudomonal beta-lactam plus gentamicin is recommended for patients with systemic compromise.

Conclusions:

  • Aggressive and timely empiric antibiotic therapy is critical for improving outcomes in pediatric cancer patients with febrile neutropenia.
  • Treatment selection should be guided by patient's clinical status, with monotherapy for stable patients and combination therapy for those with systemic compromise.
  • Effective management of infectious complications is as vital as cancer-directed therapy for survival.

Keywords:
antibiotic therapycancer.child

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Urine Studies II: Urine Culture and Sensitivity Test01:26

Urine Studies II: Urine Culture and Sensitivity Test

A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Antibiotic Selection00:57

Antibiotic Selection

Overview
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...